Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impaired platelet function in endotoxemic pigs analyzed by flow cytometry.

A Larsson1, M Eriksson, T Lundahl

  • 1Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

Platelets
|June 24, 2006
PubMed
Summary

This study investigates how bacterial toxins affect blood clotting cells in pigs and humans. Researchers found that exposure to these toxins reduces the ability of platelets to function properly, which may explain bleeding complications during severe infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pressure at the lower inflexion point has no relation to airway collapse in surfactant-treated premature lambs.

Acta anaesthesiologica Scandinavica·2001
Same author

Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.

Anticancer research·2001
Same author

Is it necessary to order aspartate aminotransferase with alanine aminotransferase in clinical practice?

Clinical chemistry·2001
Same author

Angiogenesis and angiogenic growth factors in Wilms tumor.

The Journal of urology·2001
Same author

An open and flexible framework for computer aided surgical training.

Studies in health technology and informatics·2001
Same author

Intracorporeal suturing and knot tying in surgical simulation.

Studies in health technology and informatics·2001

Area of Science:

  • Hematology research within cardiovascular medicine
  • Pathophysiology studies involving flow cytometry analysis

Background:

No prior work had fully resolved how systemic bacterial toxins alter the responsiveness of circulating clotting cells. It was already known that these toxins trigger severe inflammatory responses and systemic vascular collapse. Prior research has shown that patients suffering from severe infections often exhibit signs of abnormal blood clotting. That uncertainty drove the need to examine cellular mechanisms during these pathological states. Scientists previously observed elevated markers of cellular activation in the bloodstream during such conditions. This gap motivated a closer look at the functional capacity of these specific blood components. Understanding the underlying cellular defects remains a challenge for modern intensive care medicine. Researchers sought to clarify if these observed changes directly impair the ability of cells to aggregate.

Purpose Of The Study:

The primary aim of this investigation was to evaluate the in vivo effect of bacterial toxins on the functional capacity of clotting cells. Researchers sought to determine if these toxins directly compromise the ability of cells to participate in the coagulation process. This study was motivated by the observation that patients with severe infections frequently experience unexplained bleeding complications. The team aimed to bridge the gap between systemic inflammation and cellular dysfunction in a controlled animal model. They specifically investigated whether exposure to these toxins leads to a state of cellular exhaustion. The project also sought to validate whether findings from animal models could be replicated in human clinical populations. By examining these interactions, the authors hoped to clarify the pathophysiology of complex coagulation disorders. This work addresses the need for better diagnostic tools to assess cellular health during acute systemic illness.

Keywords:
platelet activationbacterial lipopolysaccharidecoagulation disordersporcine model

Frequently Asked Questions

The researchers propose that endotoxin infusion leads to a significant reduction in the ability of platelets to respond to adenosine-diphosphate stimulation. This functional impairment was statistically significant, with a p-value less than 0.001 compared to control subjects.

The team utilized fluorescein-labeled chicken anti-human fibrinogen to detect binding activity on the surface of the cells. This specific antibody allows for the quantification of fibrinogen receptor exposure, which serves as a proxy for functional activation capacity.

Flow cytometry is necessary because it provides a rapid, quantitative assessment of cell surface markers. Unlike traditional aggregation assays, this technique allows for the evaluation of individual cell responses in small blood volumes, which is advantageous for acute clinical monitoring.

Related Experiment Videos

Main Methods:

The investigators employed a porcine model to simulate the effects of systemic bacterial toxins. They utilized specialized fluorescent probes to track the binding of specific proteins to the cell surface. This review approach involved stimulating blood samples with chemical agonists to test cellular reactivity. The team compared the responses of treated subjects against baseline measurements taken before toxin exposure. They performed all analyses using high-throughput optical detection systems to ensure precise quantification. The experimental design focused on measuring the activation state of circulating clotting cells. Researchers collected blood samples at multiple time points to track the progression of cellular dysfunction. This systematic evaluation allowed for the direct comparison of functional changes across different experimental groups.

Main Results:

The strongest finding indicates that toxin exposure significantly impairs the responsiveness of clotting cells to chemical stimulation. Platelets from treated subjects showed a marked decrease in fibrinogen binding compared to healthy controls. The statistical analysis confirmed this reduction with a p-value of less than 0.001. Similar patterns of decreased cellular function appeared in human patients diagnosed with severe systemic infections. The data suggests that the presence of toxins in the bloodstream directly interferes with the activation pathways of these cells. These results provide evidence for a link between systemic inflammation and the loss of normal clotting capacity. The observed impairment was consistent across both the animal model and the human clinical cohort. This finding highlights a potential mechanism for the bleeding problems often seen in critically ill patients.

Conclusions:

The authors suggest that their findings offer a potential explanation for bleeding complications observed during septic shock. They propose that the observed cellular dysfunction might be a common feature of severe systemic infections. This synthesis highlights the potential utility of rapid diagnostic techniques for assessing clotting cell health in clinical settings. The researchers indicate that their data aligns with observations made in human patients. They note that the observed impairment likely contributes to the complex coagulation disorders seen in these patients. The study provides a basis for future investigations into the mechanisms of cellular exhaustion during infection. They conclude that their approach offers a practical way to monitor patients at risk of bleeding. The work emphasizes the importance of evaluating cellular responsiveness rather than just counting cell numbers.

The researchers used this data to correlate the in vivo effects of bacterial toxins with the observed cellular dysfunction. By comparing porcine models to human clinical samples, they validated the relevance of their findings to human pathology.

The study measured the binding of fibrinogen to the platelet surface following stimulation with adenosine-diphosphate. This measurement reflects the conformational change of the glycoprotein IIb/IIIa receptor, which is a key indicator of the ability of the cell to participate in clot formation.

The authors propose that this diagnostic approach could become a practical tool for managing patients with disseminated intravascular coagulation. They suggest that rapid assessment of cellular function might help clinicians anticipate and manage bleeding risks in the intensive care unit.